Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAXIMIN vs RILMENIDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAXIMIN vs RILMENIDINE: Safety Overview

Metric RIFAXIMIN RILMENIDINE
Total FAERS Reports 13,861 899
Deaths Reported 5,009 103
Death Rate 36.1% 11.5%
Hospitalizations 4,847 536
Average Patient Age 63.2 yrs 73.4 yrs
% Female Patients 54.9% 65.3%
FDA Approval Date Mar 24, 2010 N/A
Manufacturer Salix Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A